Profusa Secures $300K in Highly Dilutive Equity Line Funding with "True-Up" Mechanism
summarizeSummary
Profusa is accessing $300,000 through a highly dilutive equity line of credit with terms that protect the investor from downside, further impacting existing shareholders.
check_boxKey Events
-
Equity Line Drawdown
Profusa submitted an Advance Notice to Ascent Partners Fund LLC to purchase shares under an existing equity line of credit arrangement, with a cap of $300,000 per Advance Notice.
-
Highly Dilutive Purchase Terms
The purchase price for the shares will be 97% of the lowest volume-weighted average price (VWAP) of the common stock over the ten trading days prior to the Advance Notice date.
-
Aggressive "True-Up" Mechanism
The agreement includes a price adjustment mechanism where if the adjusted VWAP during the investor's selling period is lower than the initial closing price, Profusa will issue additional shares to Ascent, further diluting existing shareholders to protect the investor's return.
-
Continuation of Distress Financing
This financing follows a series of highly dilutive capital raises and a going concern warning, underscoring the company's critical need for funds to sustain operations.
auto_awesomeAnalysis
Profusa, a company facing severe financial distress and a going concern warning, has drawn $300,000 from its equity line of credit. The terms are highly unfavorable, allowing the investor to purchase shares at 97% of the lowest volume-weighted average price (VWAP) over 10 days and including a "True-Up Mechanism" that issues additional shares if the stock price drops further, protecting the investor from downside at the expense of existing shareholders. This continues a pattern of desperate financing to maintain operations, representing a substantial portion of the company's market capitalization.
At the time of this filing, PFSA was trading at $0.43 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $0.40 to $975.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.